Marshall Wace North America’s Definitive Healthcare DH Stock Holding History

Marshall Wace North America’s Portfolio DH Stock Details DH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$3.65M	Buy	+85,253	New	+$3.78M	0.02%	588

Other funds holding DH

Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ESCM

Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return

Tiger Global Management New York $24B AUM 39.59% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Marshall Wace North America's DH Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Definitive Healthcare (DH) in Q3 2021: 85,253 shares worth $3.65M. The stake represents 0.02% of the portfolio and ranks #588 among its holdings.

76 funds tracked by Wall St. Rank hold DH as of Q3 2021.

Marshall Wace North America held 85,253 shares of Definitive Healthcare worth $3.65M as of Q3 2021.
Definitive Healthcare was a new Marshall Wace North America position in Q3 2021.
Definitive Healthcare made up 0.02% of Marshall Wace North America's portfolio in Q3 2021, its #588 holding.
76 funds tracked by Wall St. Rank held Definitive Healthcare as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.